Comment on 'Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells'

British Journal of Cancer

Volumn 108, Issue 4, 2013, Pages 993-

  Cvek, B ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER COMPLEX; DIETHYLDITHIOCARBAMIC ACID; DISULFIRAM;

BONE METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CYTOTOXICITY; DRUG SAFETY; GLIOBLASTOMA; HUMAN; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL;

ALDEHYDE DEHYDROGENASE; BRAIN NEOPLASMS; COPPER; DISULFIRAM; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS;

EID: 84875222957     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.18     Document Type: Letter

References (7)

1. Cvek B (2011) Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome. Curr Cancer Drug Targets 11: 332-337.
2. Cvek B (2012) Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram). Drug Discov Today 17: 409-412.
3. Dufour P, Lang JM, Giron C, Duclos B, Haehnel P, Jaeck D, Jung JM, Oberling F (1993) Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study. Biotherapy 6: 9-12.
4. Johansson B (1992) A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 369: 15-26.
5. Lewison EF (1977) Spontaneous regression of breast cancer. Prog Clin Biol Res 12: 47-53.
6. Liu P, Brown S, Goktug T, Channathodiyil P, Kannappan V, Hugnot JP, Guichet PO, Bian X, Armesilla AL, Darling JL, Wang W (2012) Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDHpositive cancer-stem-like cells. Br J Cancer 107: 1488-1497.
7. Suh JJ, Pettinati HM, Kampman KM, O'Brien CP (2006) The status of disulfiram: a half of a century later. J Clin Psychopharmacol 26: 290-302.